首页 > 《岭南心血管病杂志：英文版》 > 2018年3期 > Contrast-induced nephropathy after staged percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease

Contrast-induced nephropathy after staged percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease

在线阅读下载PDF 导出详情

摘要未填写

DOI wjvr3kyk47/1881674

作者 MA Gui-zhou;XU Rong-he;WANG Ying;CHEN Shao-min;NI Chu-min;CAI Zhi-xiong

机构地区不详

出处《岭南心血管病杂志：英文版》 2018年3期

关键词梗塞心肌疾病动脉总线标准风险因素

分类 [医药卫生][心血管疾病]

出版日期 2018年03月13日（中国期刊网平台首次上网日期，不代表论文的发表时间）

相关文献

1WANG Yu;CHEN Xiao-lan;KE Zu-hui;HUANG Si-hui;YU Dan-qing. Association of klotho protein with contrast-induced nephropathy in patients with ST elevation myocardial infarction undergoing percutaneous coronary intervention.心血管疾病,2018-03.
2覃雪清;谭宁;甘富东;周颖玲;陈纪言;杨大浩. Contrast-induced nephropathy after a second percutaneous coronary intervention in patients with chronic kidney disease.心血管疾病,2011-04.
3CHEN Ming-yu;Hong Wan-zi;YU Yang;JIANG Lei;XIONG Si;LUO Chang-jun. Prognostic value of magnesium in serum of patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.心血管疾病,2018-03.
4HE Pei-yuan;YANG Yue-jin;QIAO Shu-bin;XU Bo;YAO Min;WU Yong-jian;YUAN Jin-qing;CHEN Jue;LIU Hai-bo;DAI Jun;TANG Xin-ran;WANG Yang;LI Wei;GAO Run-lin. A comparison of transradial and transfemoral approaches for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients in a high volume percutaneous coronary intervention center.心血管疾病,2014-01.
5张焕基;张新霞;吴剑胜;胡雪松. Clinical benefits of intracoronary high-dose tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.心血管疾病,2010-02.
6TUERXUNJIANG Abuduaini;LIU Yong;CHEN Shi- qun;SUN Guo-li;SAIMIRE Muhetaer;GUO Xiao-sheng;LI Hua-long;RAN Peng;YANG Jun-qing;TAN Ning;ZHOU Ying-ling;CHEN Ji-yan. The SYNTAX score as a predictor of contrast-induced nephropathy patients with chronic total occlusion undergoing percutaneous coronary intervention.心血管疾病,2018-02.
7LIU De-hui;QIN Zhi-hui. Comparison of different risk scores in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.心血管疾病,2018-02.
8张国奇;黄超龙;刘晓剑;李月亮;邱敏. Prognostic impact of chronic total occlusion in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous intervention.心血管疾病,2018-04.
9Hao Jing-Yan,Zhang Jian,Jing Rui,Liu Jing-Jing,Di Cheng-Ye,Lu Yu-Jie,Gao Peng,Wang Ya-Jie,Yang Rui-Fei,Lin Wen-Hua. Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease.医药卫生,2021-09.
10Pan Yu,Mu Yu,Liu Ze-Sen,Zhang Yu-Chen,He Ji-Qiang,Yu Xian-Peng,Qiu Qi. Impact of prior cerebrovascular events on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or percutaneous coronary intervention.医药卫生,2021-09.

来源期刊

岭南心血管病杂志：英文版

相关推荐

同分类资源更多

相关关键词

梗塞心肌疾病动脉总线标准风险因素

返回顶部